1. bookVolume 71 (2021): Edizione 1 (March 2021)
Dettagli della rivista
License
Formato
Rivista
eISSN
1846-9558
Prima pubblicazione
28 Feb 2007
Frequenza di pubblicazione
4 volte all'anno
Lingue
Inglese
Accesso libero

A cost-effective and sensitive TLC-densitometric identification of meloxicam

Pubblicato online: 20 Jul 2020
Volume & Edizione: Volume 71 (2021) - Edizione 1 (March 2021)
Pagine: 143 - 152
Accettato: 24 Mar 2020
Dettagli della rivista
License
Formato
Rivista
eISSN
1846-9558
Prima pubblicazione
28 Feb 2007
Frequenza di pubblicazione
4 volte all'anno
Lingue
Inglese

1. A. Walsem, R. Nixon, P. Guyot, A. Karabis and A. R. Moore, Relative benefit-risk comparing diclofe nac to other traditional non-steroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors in patients with osteoarthritis or rheumatoid arthritis, Arthritis Res. Ther.19 (2015) 66–72; https://doi.org/10.1186/s13075-015-0554-010.1186/s13075-015-0554-0441179325879879Search in Google Scholar

2. A. Pyka, Detection progress of selected drugs in TLC, Biomed. Res. Int.2014 (2014) Article ID 732078 (19 pages); https://doi.org/10.1155/2014/73207810.1155/2014/732078391429624551853Search in Google Scholar

3. M. Dołowy and A. Pyka-Pająk, Development of new procedures for the detection and separation of salicylic acid and acetylsalicylic acid using thin-layer chromatography with densitometry, J. Planar Chromatogr. – Modern TLC30 (2017) 363–374; https://doi.org/10.1556/1006.2017.30.5.510.1556/1006.2017.30.5.5Search in Google Scholar

4. W. Parys, K. Bober, A. Pyka-Pająk and M. Dołowy, The application of TLC and densitometry for quantitative determination of meloxicam in tablets, Curr. Pharm. Anal.15 (2019) 785–794; https://doi.org/10.2174/157341291566619021215574010.2174/1573412915666190212155740Search in Google Scholar

5. M. Starek and J. Krzek, TLC determination of meloxicam in tablets and after acidic and alkaline hydrolysis, Acta Pol. Pharm. Drug Res.69 (2012) 225–235.Search in Google Scholar

6. N. Desai and P. Amin, Stability indicating HPTLC determination of meloxicam, Indian J. Pharm. Sci.70 (2008) 644–647; https://doi.org/10.4103/0250-474X.4540610.4103/0250-474X.45406303829221394264Search in Google Scholar

7. M. Starek, Separation and determination of four oxicams in pharmaceutical formulations by thin-layer chromatographic-densitometric method, J. Planar Chromatogr. – Modern TLC24 (2011) 367–372; https://doi.org/10.1556/JPC.24.2011.5.110.1556/JPC.24.2011.5.1Search in Google Scholar

8. H. Hopkała and A. Pomykalski, TLC analysis of inhibitors of cyclooxygenase and videodensitometric determination of meloxicam and tiaprofenic acid, J. Planar Chromatogr. – Modern TLC16 (2003) 107–111; https://doi.org/10.1556/JPC.16.2003.2.410.1556/JPC.16.2003.2.4Search in Google Scholar

9. J. Shaji and D. Varkey, Development of a validated stability-indicating HPTLC method for determination of meloxicam in bulk and pharmaceutical formulations: Pertinence to ICH guidelines, Int. J. Pharm. Pharm. Sci.4 (2012) 160–169.Search in Google Scholar

10. B. Mamatha, G. Ushasree and V. U. Maheswara Rao, Analytical techniques for estimation of meloxicam in bulk and pharmaceutical dosage forms: A review, Int. J. Pharm. Res. Anal.5 (2015) 74–77.Search in Google Scholar

11. A. Noreen, S. Ahmed, Z. Anwar and I. Ahmad, Analytical techniques for determination of meloxicam in pharmaceutical formulations and biological samples, Baqai J. Health Sci.19 (2016) 59–74.Search in Google Scholar

12. International Conference of Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, ICH Harmonized Tripartite Guideline, Validation of Analytical Procedures: Text and Methodology Q2(R1), ICH, Geneva 2005; http://www.ich.org; last access date March 15, 2019.Search in Google Scholar

Articoli consigliati da Trend MD

Pianifica la tua conferenza remota con Sciendo